Last reviewed · How we verify
NCT07533227: FMT-CACH
Intestinal Microbiota Transplantation for Treating Advanced Tumor Cachexia
Phase 2 trial testing FMT capsule in Cachexia; Cancer in 66 participants. Not yet recruiting.
1 May 2027
Quick facts
| Lead sponsor | Hua Jiang |
|---|---|
| Phase | Phase 2 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 66 |
| Start date | 1 May 2026 |
| Primary completion | 1 May 2027 |
| Estimated completion | 1 May 2027 |
Drugs / interventions tested
- FMT capsule
Conditions studied
- Cachexia; Cancer — all drugs for Cachexia; Cancer →
- Fecal Microbiota Transplantation (FMT) — all drugs for Fecal Microbiota Transplantation (FMT) →
Sponsor
Hua Jiang
Who can join
18 and older, any sex, with Cachexia; Cancer or Fecal Microbiota Transplantation (FMT). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project is a prospective, multicenter, single-arm, phase II clinical study aimed at evaluating the efficacy and safety of fecal microbiota transplantation (FMT) in treating advanced tumor cachexia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07533227
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of FMT capsule
Trials testing the same drug.
- NCT07481422 — Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndro · Phase 1, PHASE2 · recruiting
- NCT06649981 — Aging Resilience Through Microbiota Optimization and Regulation · Phase 1 · active not recruiting
- NCT06920212 — Clinical Safety and Efficacy of Fecal Microbiota Transplantation (FMT) in the Treatment of Alzheimer's Disease · NA · active not recruiting
- NCT05427331 — FMT Capsules in Treatment of Patients With Insomnia Clinical Research · NA · unknown
- NCT04130763 — Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of Anti- PD-1 · Phase 1 · completed
Other recruiting trials for Cachexia; Cancer
Currently open trials in the same condition.
- NCT04406662 — Routine Evaluation of People Living With Cancer · recruiting
- NCT03568019 — PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors · active not recruiting
Other Hua Jiang trials
Trials by the same sponsor.
- NCT06801665 — FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colon Cancer With Liver Metastasis · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07533227 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hua Jiang
- Last refreshed: 16 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07533227.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing